Kyverna Therapeutics Appoints Biotech Leaders Sravan Emany and Andrew Miller to Board of Directors
Kyverna Therapeutics (NASDAQ:KYTX) was downgraded by analysts at
Wall St
Kyverna Therapeutics Appoints Mayo Pujols as Chief Technology Officer
Kyverna Therapeutics Provides Corporate Update and Outlines 2026 Strategic Priorities at the J.P. Morgan Healthcare Conference [Yahoo! Finance]
Kyverna Therapeutics Provides Corporate Update and Outlines 2026 Strategic Priorities at the J.P. Morgan Healthcare Conference